Market Overview

Kraig Biocraft Laboratories Accelerates Its Spider Silk Production Ramp up, the Result of Recent Meetings with Senior Vietnamese and US Embassy Officials

Share:

Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading
developer of spider silk based fibers, announces today that Jon Rice,
the Company's COO, held meetings with senior Vietnamese officials in
Quang Nam, and US government officials at the US Embassy in Hanoi,
Vietnam, to advance its production ramp-up plan for Prodigy Textiles
Co., Ltd.

The Company has already received its business license for Prodigy
Textiles and its investment authorization for up to $2.2 million to fund
the first phase of its spider silk commercialization scale up efforts in
Quang Nam. This approved first phase includes the importation of the
Company's hybrid silkworms and production of Prodigy Textiles' unique
high performance silk.

During the meeting with officials in Quang Nam, the Company requested an
acceleration of the project schedule, including authorization and the
investment license for the second phase of operations, with a total
investment cap of up to $50 million. The second phase of the Company's
investment plan includes the development of a 50 hectare parcel of land
and the construction of a new dedicated factory, designed to support the
Company's five year expected recombinant spider silk production output
needs. The Company has already begun to work with a local architectural
firm to develop the plans for this unprecedented facility and spider
silk production complex.

"Our meetings in Vietnam were highly productive. Working with officials
in Quang Nam, our team of consultants, and US government staff in Hanoi,
we have established a clear plan and roadmap to accelerating our efforts
to bring affordable spider silk to the global market," stated Jon Rice,
COO. "The first phase of this effort is underway now and, based on our
recent meeting, we hope to have authorization for the expanded phase two
effort well ahead of our initial schedule."

To view the most recent edition of Kraig's Spider Sense quarterly
newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com),
a reporting biotechnology company, is the leading developer of
genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global textile
industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no assurance
that management's expectations will necessarily come to pass. These
forward-looking statements generally can be identified by phrases such
as "believes," "plans," "expects," "anticipates," "foresees,"
"estimated," "hopes," "if," "develops," "researching," "research,"
"pilot," "potential," "could" or other words or phrases of similar
import. Forward looking statements include descriptions of the Company's
business strategy, outlook, objectives, plans, intentions and goals. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
those in forward-looking statements. This press release does not
constitute an offer to sell or the solicitation of an offer to buy any
security.

View Comments and Join the Discussion!